Butterfly Network Appoints Seasoned Medtech Leader Caroll Neubauer to Board
Summary
Butterfly Network announced the contingent resignation of Dr. Erica Schwartz for a potential CDC role and the appointment of Caroll H. Neubauer, a veteran medtech executive, to its Board of Directors.
Key Events
-
New Director Appointed
Caroll H. Neubauer, a seasoned medtech leader and former Chairman and CEO of B. Braun USA, was appointed to the Board of Directors, effective May 18, 2026.
-
Strategic Board Expertise
Mr. Neubauer brings three decades of experience from B. Braun, where he helped grow annual revenue from $1 billion to over $8 billion, and served on the Global Management Board.
-
Committee Assignments
Mr. Neubauer will serve on the Board's Compensation Committee and Technology Committee.
-
Contingent Director Resignation
Dr. Erica Schwartz notified the Board of her contingent resignation, effective upon her confirmation as Director of the Centers for Disease Control and Prevention (CDC) by the U.S. Senate.
Analysis
This filing details significant changes to Butterfly Network's Board of Directors. The appointment of Caroll H. Neubauer, a highly experienced medtech executive with three decades at B. Braun, including leadership of its North American operations, brings substantial industry expertise and strategic guidance to the company. His background in scaling a global medical device company and his influence in healthcare industry associations are particularly valuable as Butterfly Network aims to accelerate profitability and pursue growth initiatives. While Dr. Erica Schwartz's contingent resignation for a potential high-profile government role is notable, the immediate and strategic impact of Mr. Neubauer's appointment is more significant for the company's operational and strategic direction.
At the time of this filing, BFLY was trading at $4.36 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $1.32 to $5.72. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.